233 Studies Now Enrolling
Menu
Search
Medical Condition
- Show all (998)
- Addiction (12)
- Allergy, Asthma, & Immunology (11)
- All of Us Research Program - NIH (1)
- Autoimmune Disorders (25)
- Blood Disorders (18)
- Bone & Muscle (8)
- Cancer (91)
- Child Development (4)
- COVID-19 (Coronavirus) (28)
- Critical Illness (1)
- Diabetes (15)
- Ear, Nose and Throat (5)
- Endocrine & Metabolic Disease (11)
- Eye (7)
- Gastrointestinal and Digestive Diseases (23)
- Hair and Skin Disorders (3)
- Headaches (5)
- Healthy Volunteers (143)
- Heart Disease (109)
- Infectious Disease (39)
- Insomnia (2)
- Kidney Disease (12)
- Liver Disease (40)
- Lung Disease (29)
- Meniere's Disease (1)
- Neurological Disorders (95)
- Nutrition (3)
- Obesity (2)
- Obstetrics & Gynecology (46)
- Pain Management (1)
- Pediatrics (84)
- Psychiatric Disorders (60)
- Rehabilitation (7)
- Stroke (5)
- Surgery (7)
- Transplant (33)
- Urology (3)
- Vascular Conditions (9)
Displaying 1 - 2 of 2
Condition: Liver Disease / Liver Failure
Investigator: Elizabeth Verna, MD
Status: Closed
The purpose of this research study is to determine if an investigational drug, VS-01, will help in the treatment of acute-on-chronic liver failure (ACLF) compared to supportive care (standard of therapy). ACLF is a potentially life-threatening condition characterized by a group of signs that occur together (syndrome) in patients with a late stage of…
Condition: Cancer / Pancreatic Cancer
Investigator: Gulam Manji, MD, PhD
Status: Closed
The purpose of this study is to learn which treatment works best in patients with pancreatic cancer. The study explores multiple treatment combinations. A study drug called atezolizumab may be combined with other drugs such as cobimetinib, PEGPH20, and BL-8040. Patients may also be assigned to receive standard chemotherapy treatment.